Friday 6 November 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.

Revenue: +4.13%
EPS: −21.7%
Free cash flow: −63.7%

Quarter to September 2026, against a year earlier

561.51 4.21 −0.74%

Follow UTHR

Alert me

Market cap: $24.3B
P/E: 19.7×
Fwd P/E: 22.5×
Dividend yield: —
F-score: 8/9
Altman Z: 19.55
Beneish M: −2.26
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	6	6	7	8	+8 more TTM periods Free account
ROE Full definition →	19.13%	19.32%	20.26%	19.71%
ROA Full definition →	17.11%	17.33%	17.81%	17.51%
ROIC Full definition →	30.13%	23.44%	23.94%	22.34%
Return on Tangible Assets Full definition →	44.31%	27.28%	31.30%	27.40%
Average Days of Receivables Full definition →	0.00	35.90	35.93	40.16
Free Cash Flow per Share Full definition →	20.31	25.66	23.38	23.37
Free Cash Flow Full definition →	867.20	1,093.00	1,016.90	1,035.20
Capital Expenditures Full definition →	(562.40)	(592.20)	(546.40)	(526.00)
Other line items
Cash ROIC Full definition →	8.84%	12.06%	12.62%	10.33%
Accounts Receivable Turnover Full definition →	9.86	9.15	10.00	10.11
Accounts Payable Turnover Full definition →	0.88	0.94	0.98	0.92
Inventory Turnover Full definition →	2.30	2.41	2.47	2.25
Average Days of Payables Full definition →	0.00	415.59	427.65	463.37
Days of Inventory on Hand Full definition →	0.00	161.80	153.02	173.86
Tax Rate Full definition →	(0.18)	(0.17)	(0.20)	(0.22)
Research and Development Expense of Revenue Full definition →	22.06%	17.48%	17.01%	17.28%
Selling, General and Administrative Expense of Revenue Full definition →	22.83%	24.22%	24.29%	23.75%
Share Based Compensation of Revenue Full definition →	4.93%	4.93%	4.73%	4.64%
Interest Coverage Full definition →	111.02	116.82	87.53	76.54
Operating CF/Net income Full definition →	1.16	1.29	1.21	1.17
Depreciation/Fixed assets Full definition →	0.00	0.05	0.05	0.05
Capex/Depreciation Full definition →	(5.86)	(6.47)	(6.18)	(6.14)
Revenue per Share Full definition →	74.65	74.05	72.87	71.84
Operating CF per Share Full definition →	33.48	39.56	35.94	35.24
Capex per Share Full definition →	(13.17)	(13.90)	(12.56)	(11.87)
Capex to Sales Full definition →	0.18	0.19	0.17	0.17

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly